Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial

被引:13
|
作者
Beck, Eric N. [1 ,2 ]
Wang, Mary T. Y. [2 ,3 ]
Intzandt, Brittany N. [2 ,4 ]
Almeida, Quincy J. [2 ]
Martens, Kaylena A. Ehgoetz [2 ,5 ]
机构
[1] Univ Dublin, Sch Med, Trinity Coll Dublin, Dublin, Ireland
[2] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Movement Disorders Res & Rehabil Ctr, Waterloo, ON, Canada
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Concordia Univ, Cognit Hlth & Aging Res Lab, Montreal, PQ, Canada
[5] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada
来源
PLOS ONE | 2020年 / 15卷 / 04期
关键词
NONMOTOR SYMPTOMS; MOTOR SYMPTOMS; EXTERNAL FOCUS; BASAL GANGLIA; RATING-SCALES; GAIT CHANGES; DEPRESSION; VALIDATION; PD; NEUROPLASTICITY;
D O I
10.1371/journal.pone.0230803
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Anxiety has been implicated as one of the greatest influences on quality of life in Parkinson's disease (PD). The etiology of anxiety is unclear, although previous work suggests that anxiety may be linked to sensory deficits that cause uncertainty in movement. Thus, the current study examined whether focusing attention on sensory feedback during goal-based exercise has the potential to provide benefits to anxiety in PD. Thirty-five participants with PD were randomized to either a Sensory Attention Focused Exercise (SAFEx) (i.e. internal focus of attention, n = 18) or Sham Exercise control (i.e. external focus of attention, n = 17) and completed 33 one-hour attention-based exercise sessions over 11-weeks. Before and after the program (pre and post), participants completed the Parkinson Anxiety Scale (PAS) questionnaire. The PAS includes three anxiety sections: persistent, episodic, and avoidance. Changes in the total PAS score and within each section of the PAS were subjected to two-factor mixed repeated measures ANCOVA. Significant group by time interactions demonstrated that from pre to post, total PAS scores (p = 0.007) and episodic anxiety scores (p = 0.010) significantly decreased in the SAFEx group only (Delta Total PAS = -5.2, F-(1,F-27) = 5.41, p = 0.028, eta(2)(p) = 0.17; Delta Episodic Score = -1.8, F-(1,F-27) = 6.89, p = 0.014, eta(2)(p) = 0.20). In conclusion, focusing attention on sensory feedback while completing goal-based exercises may provide significant benefits to improving anxiety in PD. As such, sensory attention focused exercise may be a critical adjunct therapy for improving anxiety, and ultimately quality of life in people with PD.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] The cyclical lower extremity exercise for Parkinson's trial (CYCLE): methodology for a randomized controlled trial
    Rosenfeldt, Anson B.
    Rasanow, Matthew
    Penko, Amanda L.
    Beall, Erik B.
    Alberts, Jay L.
    BMC NEUROLOGY, 2015, 15
  • [42] Patient Education for Patients with Parkinson's Disease - A Randomized Controlled Trial
    Magdalena, Chlond
    Felicitas, Bergmann
    Heike, Schnoor
    Karla, Eggert
    Astrid, Larisch
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2013, 59 (01): : 68 - 69
  • [43] Caffeine as a treatment for Parkinson's disease: A randomized controlled trial (CafePD)
    Postuma, R.
    Anang, J.
    Pelletier, A.
    Moscovich, M.
    Grimes, D.
    Borys, A.
    Furtado, S.
    Munhoz, R.
    Cresswell, S.
    Moro, A.
    Hobson, D.
    Joseph, L.
    Lang, A.
    MOVEMENT DISORDERS, 2017, 32
  • [44] Randomized controlled trial of the Alexander Technique for idiopathic Parkinson's disease
    Stallibrass, C
    Sissons, P
    Chalmers, C
    CLINICAL REHABILITATION, 2002, 16 (07) : 695 - 708
  • [45] Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
    Ramig, Lorraine
    Halpern, Angela
    Spielman, Jennifer
    Fox, Cynthia
    Freeman, Katherine
    MOVEMENT DISORDERS, 2018, 33 (11) : 1777 - 1791
  • [46] A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
    Shoulson, I
    Penney, J
    McDermott, M
    Kieburtz, K
    Schwid, SR
    Kayson, E
    Chase, T
    Fahn, S
    Greenamyre, JT
    Lang, A
    Siderowf, A
    Pearson, N
    Harrison, M
    Rost-Ruffner, E
    Colcher, A
    Lloyd, M
    Matthews, M
    Pahwa, R
    McGuire, D
    Lew, MF
    Schuman, S
    Marek, K
    Broshjeit, S
    Factor, S
    Brown, D
    Feigin, A
    Mazurkiewicz, J
    Ford, B
    Jennings, D
    Dillon, S
    Comella, C
    Blasucci, L
    Janko, K
    Shulman, L
    Wiener, W
    Bateman-Rodriguez, D
    Carrion, A
    Suchowersky, O
    Lafontaine, AL
    Pantella, C
    Siemers, E
    Belden, J
    Davies, R
    Lannon, M
    Grimes, D
    Gray, P
    Martin, W
    Kennedy, L
    Adler, C
    Newman, S
    NEUROLOGY, 2001, 56 (04) : 455 - 462
  • [47] Effects of cognitive training in Parkinson's disease: A randomized controlled trial
    Petrelli, Annette
    Kaesberg, Stephanie
    Barbe, Michael T.
    Timmermann, Lars
    Fink, Gereon R.
    Kessler, Josef
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1196 - 1202
  • [48] Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial
    Troche, Michelle S.
    Curtis, James A.
    Sevitz, Jordanna S.
    Dakin, Avery E.
    Perry, Sarah E.
    Borders, James C.
    Grande, Alessandro A.
    Mou, Yuhan
    Vanegas-Arroyave, Nora
    Hegland, Karen W.
    MOVEMENT DISORDERS, 2023, 38 (02) : 201 - 211
  • [49] Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
    van der Marck, Marjolein A.
    Bloem, Bastiaan R.
    Borm, George F.
    Overeem, Sebastiaan
    Munneke, Marten
    Guttman, Mark
    MOVEMENT DISORDERS, 2013, 28 (05) : 605 - 611
  • [50] A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease
    Morris, Meg E.
    Menz, Hylton B.
    McGinley, Jennifer L.
    Watts, Jennifer J.
    Huxham, Frances E.
    Murphy, Anna T.
    Danoudis, Mary E.
    Iansek, Robert
    NEUROREHABILITATION AND NEURAL REPAIR, 2015, 29 (08) : 777 - 785